APA (7th ed.) Citation

Schwendinger, M., Thiry, G., De Vos, B., Leroux-Roels, G., Bruhwyler, J., Huygens, A., . . . Lilja, A. E. (2022). A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus. The Journal of infectious diseases, 225(8), 1399-1410. https://doi.org/10.1093/infdis/jiaa121

Chicago Style (17th ed.) Citation

Schwendinger, Michael, et al. "A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus." The Journal of Infectious Diseases 225, no. 8 (2022): 1399-1410. https://doi.org/10.1093/infdis/jiaa121.

MLA (9th ed.) Citation

Schwendinger, Michael, et al. "A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus." The Journal of Infectious Diseases, vol. 225, no. 8, 2022, pp. 1399-1410, https://doi.org/10.1093/infdis/jiaa121.